RE: Ok, my take on this7 Dec 2023 16:04
Right chaps, thanks for those thoughtful posts..
I'm relatively new here but I've been in the game long enough to dismiss posts citing £££s (at least in the next few months or years)
I agree that on potential - and proof of concept- this will be bought out (by Bio-techno) if the LDT test is good.
The lateral flow test would be a real game-changer..which , as you correctly say , is later.(as well as the transference to test for other cancers).
Just one point of caution - I've been investing in shares for many many years, and any deal with the Chinese has to be taken with a pinch of salt.
I've seen them renege on so many deals, steal patents / copyrights etc etc.
They really don't give a monkeys about ethics, and will challenge companies to go to international arbitration.
Anyway, on a plus note, this does appear to be a truly fantastic opportunity, and I would hope that funding comes from CDT shares sell-offs or minimal dilution on the drawdown/ other.
Just one more question: does anyone have any background on the 9% shareholder Martin Lang?
Thanks everyone for an informative and lively board.
TT